The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

The FDA stated in a release on Friday, "FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age." ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.

The Food & Drug Administration just announced that they had approved the aptly-named Xofluza, the first new antiviral drug in two decades, to help alleviate the symptoms of a flu infection.

The Food and Drug Administration issued an emergency authorization for the first over-the-counter, at-home combination flu and Covid test on Friday, just two days after the company that makes the ...

The agency's work is never done. — -- Still reeling from this year’s nightmare flu epidemic, the U.S. Food and Drug Administration has already begun work on next season's vaccines ...

The U.S. Food and Drug Administration approved the first flu vaccine on Friday, which does not have to be administered by a health care provider, but it won’t be available in time for this ...

The U.S. Food and Drug Administration approved the first flu vaccine on Friday, which does not have to be administered by a health care provider, but it won’t be available in time for this ...

The U.S. Food and Drug Administration approved the first flu vaccine on Friday, which does not have to be administered by a health care provider, but it won’t be available in time for this ...

The flu caused at least 35 million illnesses, 400,000 hospitalizations and 25,000 deaths in the 2023-24 season, according to estimates from the U.S. Centers for Disease Control and Prevention.